Provisional patent for weight loss compound
Friday, 27 February, 2009
Diagnostics company HealthLinx and industry group Dairy Australia have filed a provisional patent for a dairy-derived bioactive compound that has shown weight loss potential in rats.
The compound, LAP001, was identified from fractionated proteins in dairy products. It was found to reduce the production and storage of fat in rat cells.
The activity was confirmed by an independent research institute, HealthLinx said in a statement. Further analysis is being undertaken.
HealthLinx said there was the potential to develop the compound as a nutraceutical.
Breakthrough drug prevents long COVID symptoms in mice
Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...
Antibiotics hinder vaccine response in infants
Infants who received antibiotics in the first few weeks of life had significantly lower levels of...
Colossal announces 'de-extinction' of the dire wolf
Colossal Biosciences has announced what it describes as the rebirth of the dire wolf, which would...
